| pubmed-article:1652773 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1652773 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:1652773 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:1652773 | lifeskim:mentions | umls-concept:C0521428 | lld:lifeskim |
| pubmed-article:1652773 | lifeskim:mentions | umls-concept:C0021755 | lld:lifeskim |
| pubmed-article:1652773 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:1652773 | lifeskim:mentions | umls-concept:C0815105 | lld:lifeskim |
| pubmed-article:1652773 | lifeskim:mentions | umls-concept:C1550748 | lld:lifeskim |
| pubmed-article:1652773 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1652773 | pubmed:dateCreated | 1991-10-1 | lld:pubmed |
| pubmed-article:1652773 | pubmed:abstractText | In a previous investigation with mice, the paired presentation of either odor or taste cues with the peripheral (IP) administration of the immunoactive peptide interleukin-1 (IL-1) led to the conditioned enhancement of glucocorticoid production. The present study found that an initial central infusion of IL-1 in the presence of saccharin cues produced a robust taste aversion but not a conditioned elevation of either ACTH or corticosterone production. These results indicate that the glucocorticoid response induced by centrally administered IL-1 in rats is independent of the behaviorally aversive properties of this cytokine which are conditionable. The differential effects of IP versus ICV administration of IL-1 on glucocorticoid conditioning requires a clearer specification of the respective signaling mechanisms and pathways activated by these two routes of administration. | lld:pubmed |
| pubmed-article:1652773 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1652773 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1652773 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1652773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1652773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1652773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1652773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1652773 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1652773 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:1652773 | pubmed:issn | 0031-9384 | lld:pubmed |
| pubmed-article:1652773 | pubmed:author | pubmed-author:BrownRR | lld:pubmed |
| pubmed-article:1652773 | pubmed:author | pubmed-author:FalkJJ | lld:pubmed |
| pubmed-article:1652773 | pubmed:author | pubmed-author:GreenbergA... | lld:pubmed |
| pubmed-article:1652773 | pubmed:author | pubmed-author:HARTMM | lld:pubmed |
| pubmed-article:1652773 | pubmed:author | pubmed-author:ZurOO | lld:pubmed |
| pubmed-article:1652773 | pubmed:author | pubmed-author:JanzL JLJ | lld:pubmed |
| pubmed-article:1652773 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1652773 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:1652773 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1652773 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1652773 | pubmed:pagination | 691-4 | lld:pubmed |
| pubmed-article:1652773 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:meshHeading | pubmed-meshheading:1652773-... | lld:pubmed |
| pubmed-article:1652773 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1652773 | pubmed:articleTitle | Conditioned taste aversion but not adrenal activity develops to ICV administration of interleukin-1 in rats. | lld:pubmed |
| pubmed-article:1652773 | pubmed:affiliation | Department of Psychology, University of Manitoba, Winnipeg, Canada. | lld:pubmed |
| pubmed-article:1652773 | pubmed:publicationType | Journal Article | lld:pubmed |
